Drugs in MeSH Category Phosphodiesterase 5 Inhibitors
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd V | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 202659-001 | Jun 11, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 201171-003 | Mar 25, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rubicon | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204882-002 | Jun 11, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cadila Pharms Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 218045-003 | Nov 28, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Umedica | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 209302-003 | Jun 15, 2021 | BX | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | TADALAFIL | tadalafil | TABLET;ORAL | 205885-003 | Mar 29, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
